Search

Joost Oppenheim Phones & Addresses

  • 5809 Nicholson Ln, Rockville, MD 20852 (301) 881-1188
  • Washington, DC
  • 7601 Winterberry Ct, Bethesda, MD 20817 (301) 320-3217
  • 5809 Nicholson Ln APT 809, Rockville, MD 20852 (301) 320-3217

Work

Company: NATIONAL CANCER INSTITUTE Address: 1050 Boyles St Suite 2189A, Frederick, MD 21702 Phones: (301) 846-1551 (301) 846-7042

Education

School / High School: Columbia University / College of Physicians And Surgeons 1960

Languages

English

Awards

Healthgrades Honor Roll

Ranks

Certificate: Allergy & Immunology, 1977

Industries

Government Relations

Specialities

Allergy & Immunology

Professional Records

Medicine Doctors

Joost Oppenheim Photo 1

Dr. Joost J Oppenheim, Frederick MD - MD (Doctor of Medicine)

View page
Specialties:
Allergy & Immunology
Address:
NATIONAL CANCER INSTITUTE
1050 Boyles St Suite 2189A, Frederick, MD 21702
(301) 846-1551 (Phone), (301) 846-7042 (Fax)
Certifications:
Allergy & Immunology, 1977
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Columbia University / College of Physicians And Surgeons
Graduated: 1960
Medical School
King Co Hosp
Graduated: 1960
Medical School
University Of Washington Medical Center
Graduated: 1960
Medical School
U Birmingham
Graduated: 1960

Resumes

Resumes

Joost Oppenheim Photo 2

Lab Chief At Nci

View page
Position:
Lab Chief at NCI
Location:
Washington D.C. Metro Area
Industry:
Government Relations
Work:
NCI
Lab Chief

Business Records

Name / Title
Company / Classification
Phones & Addresses
Joost Oppenheim
Molecular Immunoregulation Laboratory
National Institutes of Health
Administration of Public Health Programs
9000 Rckvlle Pike Bldg 31, Bethesda, MD 20892
Joost Oppenheim
Chief Of The Laboratory Of Molecular Immunoregulation
National Institutes of Health
Administration of Public Health Programs
9000 Rockville Pike, Bethesda, MD 20892
Joost Oppenheim
Molecular Immunoregulation Laboratory
National Institutes of Health
Administration of Public Health Programs
9000 Rckvlle Pike Bldg 31, Bethesda, MD 20892
Joost Oppenheim
Chief Of The Laboratory Of Molecular Immunoregulation
National Institutes of Health
Administration of Public Health Programs
9000 Rockville Pike, Bethesda, MD 20892
Joost Oppenheim
Editor
International Soceity for Pharmacoepidemiology
Civic & Social Association
5272 Riv Rd, Bethesda, MD 20816
(301) 634-7949
Joost Oppenheim
Editor
The Society for Leukocyte Biology Inc
Noncommercial Research Organization/Scientific Society · Scientific Society
9650 Rockville Pike, Bethesda, MD 20814
(301) 634-7810

Publications

Isbn (Books And Publications)

Immunophysiology: The Role of Cells And Cytokines in Immunity And Inflammation

View page
Author

Joost J. Oppenheim

ISBN #

0195050975

Clinical Applications of Cytokines: Role in Pathogenesis, Diagnosis, and Therapy

View page
Author

Joost J. Oppenheim

ISBN #

0195071298

Cytokine Reference: A Compendium of Cytokines and Other Mediators of Host Defense

View page
Author

Joost J. Oppenheim

ISBN #

0122526708

Cytokine Reference: A Compendium of Cytokines and Other Mediators of Host Defense

View page
Author

Joost J. Oppenheim

ISBN #

0122526732

Interleukins, Lymphokines and Cytokines

View page
Author

Joost J. Oppenheim

ISBN #

0125275404

Mitogens in Immunobiology

View page
Author

Joost J. Oppenheim

ISBN #

0125275501

Cellular Functions in Immunity and Inflammation

View page
Author

Joost J. Oppenheim

ISBN #

0444005544

Monokines and Other Non Lymphocytic Cytokines: Proceedings

View page
Author

Joost J. Oppenheim

ISBN #

0471620408

Us Patents

Nucleic Acids Encoding A Novel Neutrophil Chemotactic Factor

View page
US Patent:
6376659, Apr 23, 2002
Filed:
Mar 14, 1997
Appl. No.:
08/818631
Inventors:
Kouji Matsushima - Frederick MD
Teizo Yoshimura - Frederick MD
Edward J. Leonard - Chevy Chase MD
Joost Oppenheim - Bethesda MD
Ettore Appella - Chevy Chase MD
Stephen D. Showalter - Frederick MD
Assignee:
The United States of America, as represented by the Department of Health and Human Services - Washington DC
International Classification:
C12N 1519
US Classification:
536 235, 435 695, 4353201
Abstract:
An isolated, synthetic preparation of a novel neutrophil-specific chemotactic factor (NCF), monoclonal antibodies having specific binding affinity of NCF and a clone containing the complete cDNA coding sequence for NCF are disclosed.

Amyloid Beta Is A Ligand For Fpr Class Receptors

View page
US Patent:
20050130890, Jun 16, 2005
Filed:
Apr 23, 2004
Appl. No.:
10/831524
Inventors:
Ji Wang - Frederick MD,
Yingying Le - Shanghai,
WangHua Gong - Frederick MD,
Hiroshi Yazawa - Frederick MD,
Joost Oppenheim - Bethesda MD,
Philip Murphy - Rockville MD,
International Classification:
G01N033/53
G01N033/567
A61K038/17
C07K014/705
US Classification:
514012000, 530350000, 435007200
Abstract:
The invention relates to the discovery that amyloid β is a ligand for FPR class receptors, which mediate the inflammation associated with Alzheimer's disease.

Method Of Treating Inflammation With Antibodies To Neutrophil Chemotactic Factor

View page
US Patent:
59253525, Jul 20, 1999
Filed:
Sep 23, 1997
Appl. No.:
8/935560
Inventors:
Kouji Matsushima - Frederick MD
Teizo Yoshimura - Frederick MD
Edward J. Leonard - Chevy Chase MD
Joost Oppenheim - Bethesda MD
Ettore Appella - Chevy Chase MD
Stephen D. Showalter - Frederick MD
Assignee:
The United States of America as represented by the Department of Health
and Human Services - Washington DC
International Classification:
A61K 39395
US Classification:
4241581
Abstract:
An isloated, synthetic preparation of a novel neutrophil-specific chemotactic factor (NCF), monoclonal antibodies having specific binding affinity for NCF and a clone containing the complete cDNA coding sequence for NCF are disclosed.

Antibodies Specific For Neutrophic Chemotactic Factor

View page
US Patent:
56981961, Dec 16, 1997
Filed:
Jun 6, 1995
Appl. No.:
8/467612
Inventors:
Kouji Matsushima - Frederick MD
Teizo Yoshimura - Frederick MD
Edward J. Leonard - Chevy Chase MD
Joost Oppenheim - Bethesda MD
Ettore Appella - Chevy Chase MD
Stephen D. Showalter - Frederick MD
Assignee:
The United States of America as represented by the Secretary, Department
of Health and Human Services - Washington DC
International Classification:
A61K 39395
C07K 1624
C12N 516
C12P 2108
US Classification:
4241391
Abstract:
The present invention relates to an isolated, synthetic preparation of a novel neutrophil-specific chemotactic factor (NCF), monoclonal antibodies having specific binding affinity for NCF and a clone containing the complete coding sequence for NCF.

Hmgn Polypeptides As Immune Enhancers And Hmgn Antagonists As Immune Suppressants

View page
US Patent:
20120269839, Oct 25, 2012
Filed:
Jun 26, 2012
Appl. No.:
13/533492
Inventors:
De Yang - Frederick MD,
Joost J. Oppenheim - Bethesda MD,
Michael Bustin - Rockville MD,
Assignee:
The U.S.A. as represented by the Secretary,Depart. of Health and Human Services - Bethesda MD
International Classification:
A61K 39/00
A61P 37/06
A61K 39/07
A61P 37/04
US Classification:
4241851
Abstract:
A method of enhancing an antigen-specific immune response in a host comprising administering to the host an HMGN polypeptide comprising at least one of HMGN1, HMGN3a, HMGN3b, HMGN4, Nsbp1, or a functional fragment thereof, in an amount effective to enhance an antigen-specific immune response; as well as a pharmaceutical composition comprising an HMGN polypeptide comprising at least one of HMGN1, HMGN3a, HMGN3b, HMGN4, Nsbp1, or a functional fragment thereof, and an antigen, or nucleic acids encoding such molecules; and related methods and compositions.

Methods And Compositions For Inhibiting Hiv-Coreceptor Interactions

View page
US Patent:
20060116325, Jun 1, 2006
Filed:
Feb 15, 2002
Appl. No.:
10/468182
Inventors:
Oleg Chertov - Frederick MD,
Joost Oppenheim - Bethesda MD,
Xin Chen - Frederick MD,
Connor McGrath - Union Bridge MD,
Raymond Sowder - Frederick MD,
Jacek Lubkowski - Frederick MD,
Michele Wetzel - Souderton PA,
Thomas Rogers - North Wales PA,
International Classification:
A61K 38/10
US Classification:
514013000, 514014000
Abstract:
Novel methods and compositions are provided for inhibiting interactions between human immunodeficiency viruses (HIVs) and viral coreceptors, including CXCR4 and/or CCR5 coreceptors. The anti-coreceptor binding agent includes a novel peptide portion of the gp120 envelope protein of HIV-1, as well as peptide analogs and mimetics of this peptide, that specifically binds to, or modulates activity of, the coreceptors(s). The anti-coreceptor binding agent is useful as a prophylactic or therapeutic treatment to prevent or inhibit HIV binding to a susceptible cell and thereby reduces infection and/or moderates or treats related diseases. In alternative embodiments, the peptides, analogs and mimetics are effective to inhibit direct co-receptor binding by HIV virus, coreceptor binding by HIV gp120 proteins or peptides, HIV fusion with target host cells, HIV virion entry into host cells, HIV replication, and HIV transmission between cells and hosts. In more detailed embodiments, the anti-coreceptor binding agents of the invention are multi-tropic by exhibiting activity against HIV interactions with multiple, CXCR4 and CCR5, coreceptors.

Cathepsin G-Related Peptides As Modulators Of Formylpeptide Receptors (Fpr)

View page
US Patent:
20060008891, Jan 12, 2006
Filed:
Jun 17, 2005
Appl. No.:
11/154744
Inventors:
Ji Wang - Frederick MD,
Ronghua Sun - Frederick MD,
Joost Oppenheim - Frederick MD,
Thomas Rogers - Philadelphia PA,
Assignee:
The Government of USA as repersented by the Secretary, Department of Health and Human Services - Rockville MD
International Classification:
C12N 9/64
US Classification:
435226000, 530350000
Abstract:
The present invention relates, e.g., to a method for identifying a peptide of CaG, or an active variant thereof, that modulates a CaG-FPR response (e.g., chemotaxis), comprising screening a candidate CaG peptide or active variant thereof for its ability to modulate a CaG-FPR induced response. Methods for identifying peptide mimetics of CaG, peptides that are more potent agonists of FPR than is CaG, and antagonists of FPR are described.

Compositions And Methods For Enhancing An Immune Response

View page
US Patent:
20060008808, Jan 12, 2006
Filed:
Apr 29, 2004
Appl. No.:
10/834733
Inventors:
De Yang - Frederick MD,
Joost Oppenheim - Bethesda MD,
Helene Rosenberg - Bethesda MD,
International Classification:
C12Q 1/68
US Classification:
435006000
Abstract:
The invention provides compositions and methods of enhancing an immune response in a subject. The compositions comprise eosinophil derived-neurotoxin (EDN) and/or human pancreatic ribonuclease (hPR), which can be used as adjuvants to elicit an enhanced immune response in a subject.
Joost J Oppenheim from Rockville, MD, age ~87 Get Report